What's new

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 17, Status: Authorised

Apr 8, 2025 - 14:24
 0
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Cartesian’s CAR-T may help autoimmune patients long term

Next Article

An animal source of mpox emerges — and it’s a squirrel

Related Posts

PSUSA/00000406/202408

PSUSA/00000406/202408

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0